Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

Metoclopramide was shown to be potentially mutagenic and clastogenic in cultured rodent and human cells in contrast to procainamide, another benzamide drug. Mutations occurred in V79 cells (Martelli et al, 1995; Mereto et al, 1995). DNA breaks, inhibition of DNA repair and micronuclei formation in human peripheral blood lymphocytes have been demonstrated with metoclopramide. Doses used were approximately 100 times higher than therapeutic doses, thus it may be considered as a weak promoter (Lybak & Pero, 1991; Mereto et al, 1995; Martelli et al, 1995).

Metoclopramide. POISINDEX® System: Klasco RK: POISINDEX® System. Truven Health Analytics, Greenwood Village, Colorado.

Justification for classification or non-classification

Available data are inconclusive for a reliable assessment of germ cell mutagenicity of metoclopramide.